Abbott receives US FDA clearance and CE Mark for next-generation Ultreon 3.0 AI-powered coronary imaging platform: Abbott Park, Illinois Thursday, April 30, 2026, 14:00 Hrs [IST] ...
Ultreon 3.0 is the first advanced optical coherence tomography (OCT) system in the U.S. and Europe that integrates high resolution coronary plaque images and AI-automated ...
Abbott (NYSE:ABT) announced today that it received FDA clearance and CE mark for its next-generation Ultreon 3.0 software.
We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Pat Howard is a licensed insurance professional specializing in home insurance. He ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results